p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer (Q36702494)

15 August 2017

p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer (English)

1 reference

15 August 2017

1 reference

Mila Ghosh

1 reference

15 August 2017

Puja Sakhuja

series ordinal

1 reference

15 August 2017

Shivendra Singh

series ordinal

1 reference

15 August 2017

Anil K Agarwal

series ordinal

1 reference

15 August 2017

1 January 2013

1 reference

Saudi Journal of Gastroenterology

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

34-39

1 reference

Co-expression of cox-2, C-met and beta-catenin in cells forming invasive front of gallbladder cancer

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

p53 tumour suppressor gene protein expression in early and advanced gallbladder carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Frequent beta-catenin alteration in gallbladder carcinomas.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Tumour suppressor gene expression correlates with gastric cancer prognosis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Subserous gallbladder carcinoma: expression of cadherine-catenine complex

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Mutation and altered expression of beta-catenin during gallbladder carcinogenesis.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603488

Overexpression of p53 protein in gallbladder carcinoma in North India

5 September 2018

1 reference

12 December 2020

Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis

1 reference

12 December 2020

Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery

1 reference

12 December 2020

Expression of p53 in adenocarcinoma of the gallbladder and bile ducts

1 reference

12 December 2020

p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions

1 reference

12 December 2020

Identifiers

DOI

10.4103/1319-3767.105922

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23319036

1 reference